ROADS: Cesium-131 tile-based radiation improves local control and survival in patients with resected brain metastases

Gastrointestinal Cancer

Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis

Eur J Cancer

Bregni G, Leurquin B, Giasafaki P, Takemura N, Kokudo N, Hasegawa K, Matsuyama Y, Nishioka Y, Aparicio T, Guimbaud R, Malicot KL, Tu D, O'Callaghan C, Lutz MP, Fontana E, Moehler M, Mauer ME, Sclafani F

doi: 10.1016/j.ejca.2025.116092

Breast Cancer

Association of recurrence patterns and outcome with HR and HER2 status in patients with resected brain metastases from breast cancer

Int J Cancer

Weller J, Katzendobler S, Thiele F, Riesberg A, Harter PN, Klauschen F, Wuerstlein R, Schoenecker S, Escudero MP, Forbrig R, Thon N, Ringel F, Weller M, Le Rhun E, Stoecklein VM

doi: 10.1002/ijc.70407

Lung, Respiratory and Thoracic Cancer

Clinical risk factors for developing brain metastases during first-line (chemo-)immunotherapy in patients with non-small cell lung cancer without known baseline brain metastases

Lung Cancer

Huijs JWJ, Sadowska AM, Degens JHRJ, Steendam CMJ, Bensch F, Hijmering-Kappelle LBM, de Schrevel TMT, van Geffen WH, Youssef-El Soud M, Steens MMH, Pitz C, De Ruysscher DKM, Hendriks LEL

doi: 10.1016/j.lungcan.2025.108745

Genitourinary Cancer

Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study

Lancet Oncol

Gupta S, Loriot Y, Van der Heijden MS, Bedke J, Valderrama BP, Kikuchi E, Fléchon A, Petrylak D, De Santis M, Galsky MD, Lee JL, Swami U, Sridhar SS, De Giorgi U, Wright P, Shih V, Lu YT, Guan X, Dillon R, Shetty A, Moreno BH, Beaumont JL, Purnajo I, McManus S, Powles T

doi: 10.1016/S1470-2045(25)00158-5

Gastrointestinal Cancer

Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort

J Clin Oncol

Moon AM, Yanagihara TK, Dawson LA, Yu JI, Lawrence TS, Kim TH, Yan M, Iwata H, Nabavizadeh N, Apisarnthanarax S, Dunne EM, Lock MI, Chuong MD, Chiang CL, Scorsetti M, Katoh N, Sioshansi S, Numata K, Liu HY, Iwamoto H, Wakatsuki M, Chen Y, Pollom EL, Gkika E, Jabbour SK, Munoz-Schuffenegger P, Dutta D, Hajj C, Ueno M, Hallemeier CL, Feldman AM, Méndèz Romero A, Tan X, Molla M, Tepper JE, Torres F, Reig M, EBRT Collaboration Group

doi: 10.1200/JCO-25-02399

CHICAGO 2026

Multiple Myeloma (MM)

MajesTEC-9: Teclistamab significantly improves survival outcomes in patients with RRMM

Lung, Respiratory and Thoracic Cancer

Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis

Lancet Oncol

Di Federico A, Stumpo S, Mantuano F, De Giglio A, Lo Bianco F, Pecci F, Alessi JV, Wang X, Sperandi F, Melotti B, Gelsomino F, Skoulidis F, Garassino MC, Peters S, Awad MM, Ardizzoni A, Ricciuti B

doi: 10.1016/S1470-2045(25)00429-2

ESMO 2025

Gastrointestinal Cancer

MATTERHORN: Durvalumab plus FLOT improves OS in patients with resectable gastric and gastroesophageal junction adenocarcinoma

Further Publications

Neurocognitive outcomes in patients with brain metastases: a systematic review

Lancet Oncol

Bou Dargham T, Winter SF, Batich K, Gehring K, Parsons MW, Dietrich J, Mullikin T, Reitman ZJ, Floyd SR, Kirkpatrick JP, Sperduto PW, Hattangadi-Gluth J, Shih HA, Brown PD, Mehta M, Sulman EP, Peters KB, Vaios EJ

doi: 10.1016/S1470-2045(25)00525-X

Related content

Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis

Association of recurrence patterns and outcome with HR and HER2 status in patients with resected brain metastases from breast cancer

Clinical risk factors for developing brain metastases during first-line (chemo-)immunotherapy in patients with non-small cell lung cancer without known baseline brain metastases

Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study

Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort

MajesTEC-9: Teclistamab significantly improves survival outcomes in patients with RRMM

Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis

MATTERHORN: Durvalumab plus FLOT improves OS in patients with resectable gastric and gastroesophageal junction adenocarcinoma

Neurocognitive outcomes in patients with brain metastases: a systematic review